AU5979600A - Selective m2 muscarinic receptor antagonists having 5h-dibenz[b,f]azepine structure - Google Patents

Selective m2 muscarinic receptor antagonists having 5h-dibenz[b,f]azepine structure

Info

Publication number
AU5979600A
AU5979600A AU59796/00A AU5979600A AU5979600A AU 5979600 A AU5979600 A AU 5979600A AU 59796/00 A AU59796/00 A AU 59796/00A AU 5979600 A AU5979600 A AU 5979600A AU 5979600 A AU5979600 A AU 5979600A
Authority
AU
Australia
Prior art keywords
dibenz
selective
receptor antagonists
muscarinic receptor
azepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59796/00A
Inventor
Bruno Pietro Imbimbo
Stefano Maiorana
Giacomina Roberta Mandelli
Patrizia Maria Luisa Terni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mediolanum Farmaceutici SpA
Original Assignee
Mediolanum Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici SpA filed Critical Mediolanum Farmaceutici SpA
Publication of AU5979600A publication Critical patent/AU5979600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59796/00A 1999-07-01 2000-06-28 Selective m2 muscarinic receptor antagonists having 5h-dibenz[b,f]azepine structure Abandoned AU5979600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI99A001452 1999-07-01
IT1999MI001452A ITMI991452A1 (en) 1999-07-01 1999-07-01 SELECTIVE ANTAGONISTS FOR M2 RECEPTORS WITH STRUCTURE 5H-DIBENZO B, FAZEPINICA
PCT/EP2000/006020 WO2001002386A1 (en) 1999-07-01 2000-06-28 SELECTIVE M2 MUSCARINIC RECEPTOR ANTAGONISTS HAVING 5H-DIBENZ[b,f]AZEPINE STRUCTURE

Publications (1)

Publication Number Publication Date
AU5979600A true AU5979600A (en) 2001-01-22

Family

ID=11383261

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59796/00A Abandoned AU5979600A (en) 1999-07-01 2000-06-28 Selective m2 muscarinic receptor antagonists having 5h-dibenz[b,f]azepine structure

Country Status (3)

Country Link
AU (1) AU5979600A (en)
IT (1) ITMI991452A1 (en)
WO (1) WO2001002386A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007109794A (en) 2004-08-19 2008-09-27 Вертекс Фармасьютикалз, Инкорпорейтед (Us) MUSCARINE RECEPTOR MODULATORS
US7786141B2 (en) 2004-08-19 2010-08-31 Vertex Pharmaceuticals Incorporated Dihydrospiroindene modulators of muscarinic receptors
AU2005309365B2 (en) 2004-11-29 2011-10-06 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
AU2006330866A1 (en) 2005-12-22 2007-07-05 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
EP1988892A2 (en) 2006-02-22 2008-11-12 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
ATE517106T1 (en) 2006-02-22 2011-08-15 Vertex Pharma CONDENSED SPIROPIPERIDINE AS MODULATORS OF MUSCARINOUS RECEPTORS
CN101500565A (en) 2006-06-29 2009-08-05 弗特克斯药品有限公司 Modulators of muscarinic receptors
CN101553231A (en) 2006-08-15 2009-10-07 弗特克斯药品有限公司 Modulators of muscarinic receptors
JP2010501561A (en) 2006-08-18 2010-01-21 バーテックス ファーマシューティカルズ インコーポレイテッド Modulator of muscarinic receptor
PT2178858E (en) * 2007-08-02 2012-02-24 Recordati Ireland Ltd Novel heterocyclic compounds as mglu5 antagonists
CA2700724A1 (en) 2007-10-03 2009-04-09 Vertex Pharmaceuticals Incorporated Modulators of muscarinic receptors
US20180360845A1 (en) * 2015-07-20 2018-12-20 Chase Pharmaceuticals Corporation Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for treating hypocholinergic disorders
CN115448871B (en) * 2022-08-30 2023-07-11 中国药科大学 Preparation method of tirofiban hydrochloride

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3638950B2 (en) * 1993-04-05 2005-04-13 マンカインド コーポレイション M for treatment of neurological disorders
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands

Also Published As

Publication number Publication date
ITMI991452A1 (en) 2001-01-01
ITMI991452A0 (en) 1999-07-01
WO2001002386A1 (en) 2001-01-11

Similar Documents

Publication Publication Date Title
SG93251A1 (en) 1,2,4,5-tetrahydro-benzo[d]azepines
AU5274499A (en) Therapeutic chemokine receptor antagonists
AU8689798A (en) Integrin receptor antagonists
SG80041A1 (en) Muscarinic receptor antagonists
EP1150965A4 (en) Benzazepine derivatives as alpha-v integrin receptor antagonists
EP1194151A4 (en) Integrin receptor antagonists
EP1229910A4 (en) Integrin receptor antagonists
AU5979600A (en) Selective m2 muscarinic receptor antagonists having 5h-dibenz[b,f]azepine structure
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
GB9903767D0 (en) Receptor assay
AU2441801A (en) Urotensin-ii receptor antagonists
AU6990000A (en) Novel integrin receptor antagonists
AU1073501A (en) Histamine receptor
AU2002216079A1 (en) Bombesin receptor antagonists
AU5786300A (en) Muscarinic antagonists
AU2001249573A1 (en) Chemokine receptor antagonists
AU4980999A (en) A3 adenosine receptor antagonists
IL146146A0 (en) Integrin receptor antagonists
AU2574801A (en) Selective iGLUR5 receptor antagonists
AU2002217095A1 (en) Bombesin receptor antagonists
ZA200109627B (en) IL-8 receptor antagonists.
AU4511901A (en) Nonpeptide kappa opioid receptor antagonists
AU2234199A (en) Il-8 receptor antagonists
AU2162000A (en) Seven transmembrane domain receptor zsig56
AU6051200A (en) Il-8 receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase